CELU Celularity Inc

USD 2.92 -0.10 -3.311258
Icon

Celularity Inc (CELU) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 2.92

-0.10 (-3.31)%

USD 0.06B

0.03M

N/A

USD 1.45 (-50.34%)

Icon

CELU

Celularity Inc (USD)
COMMON STOCK | NSD
USD 2.92
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.06B

USD 1.45 (-50.34%)

USD 2.92

Celularity Inc (CELU) Stock Forecast

N/A

Based on the Celularity Inc stock forecast from 0 analysts, the average analyst target price for Celularity Inc is not available over the next 12 months. Celularity Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Celularity Inc is Very Bearish, which is based on 0 positive signals and 6 negative signals. At the last closing, Celularity Inc’s stock price was USD 2.92. Celularity Inc’s stock price has changed by -8.46% over the past week, -4.26% over the past month and -48.13% over the last year.

No recent analyst target price found for Celularity Inc
No recent average analyst rating found for Celularity Inc

Company Overview Celularity Inc

Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The co...Read More

https://www.celularity.com

170 Park Avenue, Florham Park, NJ, United States, 07932

225

December

USD

USA

Adjusted Closing Price for Celularity Inc (CELU)

Loading...

Unadjusted Closing Price for Celularity Inc (CELU)

Loading...

Share Trading Volume for Celularity Inc Shares

Loading...

Compare Performance of Celularity Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for CELU

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Celularity Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc +4.34 (+0.88%) USD126.85B 31.94 20.00

ETFs Containing CELU

Symbol Name CELU's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Celularity Inc (CELU) Stock

Stock Target Advisor's fundamental analysis for Celularity Inc's stock is Very Bearish.

Unfortunately we do not have enough data on CELU's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on CELU's stock to indicate what its average analyst target is.

CELU stock's Price/Earning ratio is 2.15. Our analysis grades CELU stock's Price / Earning ratio at D-. This means that CELU stock's Price/Earning ratio is above 38% of the stocks in the Biotechnology sector in the NSD exchange. Based on this CELU may be fairly valued for its sector

The last closing price of CELU's stock was USD 2.92.

The most recent market capitalization for CELU is USD 0.06B.

Unfortunately we do not have enough analyst data on CELU's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Celularity Inc's stock.

As per our most recent records Celularity Inc has 225 Employees.

Celularity Inc's registered address is 170 Park Avenue, Florham Park, NJ, United States, 07932. You can get more information about it from Celularity Inc's website at https://www.celularity.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...